CAUTION :
This solution should be used with care in patients with heart failure, sodium retention with edema, patients with renal failure, severe sepsis and pre-post trauma. ATTENTION :
Do not use if the bottle is damaged, has cloudy solution or contains particles. DRUG INTERACTIONS :
This solution should not be added to blood tranfusions since it may cause red blood cell coagulation and hemolytic condition.
STORAGE CONDITION :
The product has to be stored below 30 C.
PRESCRIPTION ONLY PACKAGING : Plastic Bottle 250 mL
Plastic Bottle 500 mL Plastic Bottle 1000 mL REG. No :
PRODUCED BY :
PT. Satoria Aneka Industri, Pasuruan – Jawa Timur - A low pH solution (3,5-5,0) may causes thrombophebitis.
- Reactions that may occur because of the solution or the technique of administration include febrile response, infection at site of injection, thrombosis or vein phlebitis extending from the site of injection and extravasation.
Each of 500 mL solution contains of : Dextrose monohydrate 25.00 g Water for Injection ad 500 mL Osmolarity 252 mOsm/L Equivalent to 800 kJ/L (190 kkal/L) DRUG MECHANISM :
- Carbohydrate as a source of energy for body and for maintaining body fluids. INDICATION :
To treat dehydration, provide source of calories, and restore electrolyte balance. DOSAGE AND ADMINISTRATION :
- The flow rate recommended for IV injections 3,0 mL / kg bodyweight / hour ; this is about 70 drops / 70 kg bodyweight / minute.
- Maximum dosage is 1.5 - 3.0 gram dextrose / kg bodyweight / day. CONTRAINDICATION :
Patient with hyperhydration, acidosis, diabetes mellitus, and mal-absorption glucose – galactose syndrome.
INTRAVENOUS SOLUTION
DEXTROSE 5%
CAUTION :
This solution should be used with care in patients with heart failure, sodium retention with edema, patients with renal failure, severe sepsis and pre-post trauma. ATTENTION :
Do not use if the bottle is damaged, has cloudy solution or contains particles. DRUG INTERACTIONS :
This solution should not be added to blood tranfusions since it may cause red blood cell coagulation and hemolytic condition.
STORAGE CONDITION :
The product has to be stored below 30 C.
PRESCRIPTION ONLY PACKAGING : Plastic Bottle 250 mL
Plastic Bottle 500 mL Plastic Bottle 1000 mL REG. No :
PRODUCED BY :
PT. Satoria Aneka Industri, Pasuruan – Jawa Timur - A low pH solution (3,5-5,0) may causes thrombophebitis.
- Reactions that may occur because of the solution or the technique of administration include febrile response, infection at site of injection, thrombosis or vein phlebitis extending from the site of injection and extravasation.
- Stop immediately and evaluate patients if side effect develop. Each of 500 mL solution contains of :
Dextrose monohydrate 25.00 g Water for Injection ad 500 mL Osmolarity 252 mOsm/L Equivalent to 800 kJ/L (190 kkal/L) DRUG MECHANISM :
- Carbohydrate as a source of energy for body and for maintaining body fluids. INDICATION :
To treat dehydration, provide source of calories, and restore electrolyte balance. DOSAGE AND ADMINISTRATION :
- The flow rate recommended for IV injections 3,0 mL / kg bodyweight / hour ; this is about 70 drops / 70 kg bodyweight / minute.
- Maximum dosage is 1.5 - 3.0 gram dextrose / kg bodyweight / day. CONTRAINDICATION :
Patient with hyperhydration, acidosis, diabetes mellitus, and mal-absorption glucose – galactose syndrome.
CAUTION :
This solution should be used with care in patients with heart failure, sodium retention with edema, patients with renal failure, severe sepsis and pre-post trauma. ATTENTION :
Do not use if the bottle is damaged, has cloudy solution or contains particles. DRUG INTERACTIONS :
This solution should not be added to blood tranfusions since it may cause red blood cell coagulation and hemolytic condition.
STORAGE CONDITION :
The product has to be stored below 30 C.
PRESCRIPTION ONLY PACKAGING : Plastic Bottle 250 mL
Plastic Bottle 500 mL Plastic Bottle 1000 mL REG. No :
PRODUCED BY :
PT. Satoria Aneka Industri, Pasuruan – Jawa Timur Each of 500 mL solution contains of :
Dextrose monohydrate 50.00 g Water for Injection ad 500 mL Osmolarity 505 mOsm/L Equivalent to 1600 kJ/L (380 kkal/L) DRUG MECHANISM :
- Carbohydrate as a source of energy for body and for maintaining body fluids. INDICATION :
To treat dehydration, provide source of calories, and restore electrolyte balance. DOSAGE AND ADMINISTRATION :
- The flow rate recommended for IV injections 3,0 mL / kg bodyweight / hour ; this is about 70 drops / 70 kg bodyweight / minute.
- Maximum dosage 1.5 -3.0 gram dextrose / kg bodyweight / day. CONTRAINDICATION :
Patient with hyperhydration, acidosis, diabetes mellitus, and mal-absorption glucose – galactose syndrome.
SIDE EFFECTS :
- A low pH solution (3,5-5,0) may causes thrombophebitis.
- Reactions that may occur because of the solution or the technique of administration include febrile response, infection that site of injection, thrombosis or vein phlebitis extending from the site of injection and extravasation.
INTRAVENOUS SOLUTION
DEXTROSE 10%
CAUTION :
This solution should be used with care in patients with heart failure, sodium retention with edema, patients with renal failure, severe sepsis and pre-post trauma. ATTENTION :
Do not use if the bottle is damaged, has cloudy solution or contains particles. DRUG INTERACTIONS :
This solution should not be added to blood tranfusions since it may cause red blood cell coagulation and hemolytic condition.
STORAGE CONDITION :
The product has to be stored below 30 C.
PRESCRIPTION ONLY PACKAGING : Plastic Bottle 250 mL
Plastic Bottle 500 mL Plastic Bottle 1000 mL REG. No :
PRODUCED BY :
PT. Satoria Aneka Industri, Pasuruan – Jawa Timur Each of 500 mL solution contains of :
Dextrose monohydrate 50.00 g Water for Injection ad 500 mL Osmolarity 505 mOsm/L Equivalent to 1600 kJ/L (380 kkal/L) DRUG MECHANISM :
- Carbohydrate as a source of energy for body and for maintaining body fluids. INDICATION :
To treat dehydration, provide source of calories, and restore electrolyte balance. DOSAGE AND ADMINISTRATION :
- The flow rate recommended for IV injections 3,0 mL / kg bodyweight / hour ; this is about 70 drops / 70 kg bodyweight / minute.
- Maximum dosage 1.5 -3.0 gram dextrose / kg bodyweight / day. CONTRAINDICATION :
Patient with hyperhydration, acidosis, diabetes mellitus, and mal-absorption glucose – galactose syndrome.
SIDE EFFECTS :
- A low pH solution (3,5-5,0) may causes thrombophebitis.
- Reactions that may occur because of the solution or the technique of administration include febrile response, infection that site of injection, thrombosis or vein phlebitis extending from the site of injection and extravasation.
CAUTION :
- This solution should be used with care in patients with heart failure, sodium retention with edema, severe sepsis and pre-post trauma.
- This solution should be administered with caution to patients with hepatic impairment. - Solutions containing potassium ions should be used with great care in patients with
hyperkalemia and in conditions in which potassium ions retention is present. - The administration of intravenous solutions can cause fluid and solute overload
resulting in dilution of serum electrolyte concentrations, overhydration, congested states and pulmonary edema.
ATTENTION :
- Don’t mix this solution with solutions containing phospate.
- Do not use if the bottle is damaged, has cloudy solution, or contains particles. SIDE EFFECTS :
- Reactions that may occur because of the solution or the technique of administration include febrile response, infection that site of injection, thrombosis or phlebitis extending from the site of injection and extravasation.
- Stop immediately and evaluate patients if side effects develop. STORAGE CONDITION :
The product has to be stored below 30 C.
PRESCRIPTION ONLY PACKAGING : Plastic Bottle 250 mL
Plastic Bottle 500 mL Plastic Bottle 1000 mL REG.No :
PRODUCED BY : Each of 500 mL soluition contains:
Calcium Chloride ( CaCl .2H O ) 2 2 0.10 g Ion Equivalent : +
Potassium Chloride ( KCl ) 0.15 g Na 130 mEq/L +
Sodium Chloride ( NaCl ) 3.00 g K 4 mEq/L Sodium Lactate ( C H NaO ) 3 5 3 1.60 g Lactate ( HCO ) 27.5 mEq/L3
-Water for Injection ad 500 mL Cl 109.5 mEq/L ++
Osmolarity 274 mOsm/L Ca 2.7 mEq/L DRUG MECHANISM :
- Sodium Chloride is a salt which is essential to maintain osmotic blood pressure and body tissues.
- Potassium Chloride is a salt to treat hypokalemia and/or hypochloremia condition. - Sodium Lactate is a salt needed for urgent treatment of metabolic acidosis condition. - Calcium Chloride is a salt which is important to maintain normal muscular and nerve
functions. INDICATION :
- To replace lost body fluids in acid-base or minor acidosis condition. - As a first hand solution to replace lost body fluids in an emergency situation. - A therapy to maintain the balance of body fluid in pre-during-post operation situations. - To solve dehydration of irterstitial liquid which is administered after colloid liquid has
been delivered.
DOSAGE AND ADMINISTRATION :
The flow rate recommended for IV injection is 2.5 mL/kg bodyweight/ hour ; this is about 60 drops/70 kg bodyweight/minute or 180 mL/70 kg bodyweight/hour.
CONTRAINDICATION :
- Patient with hyperhydration, hypernatremia, hyperkalemia conditions. - Patient with renal failure, severe hepatic insufficiency and lactic acidosis.
Larutan infus untuk sediaan intravena
RINGER LACTATE
CAUTION :
- This solution should be used with care in patients with heart failure, sodium retention with edema, severe sepsis and pre-post trauma.
- This solution should be administered with caution to patients with hepatic impairment. - Solutions containing potassium ions should be used with great care in patients with
hyperkalemia and in conditions in which potassium ions retention is present. - The administration of intravenous solutions can cause fluid and solute overload
resulting in dilution of serum electrolyte concentrations, overhydration, congested states and pulmonary edema.
ATTENTION :
- Don’t mix this solution with solutions containing phospate.
- Do not use if the bottle is damaged, has cloudy solution, or contains particles. SIDE EFFECTS :
- Reactions that may occur because of the solution or the technique of administration include febrile response, infection that site of injection, thrombosis or phlebitis extending from the site of injection and extravasation.
- Stop immediately and evaluate patients if side effects develop. STORAGE CONDITION :
The product has to be stored below 30 C.
PRESCRIPTION ONLY PACKAGING : Plastic Bottle 250 mL
Plastic Bottle 500 mL Plastic Bottle 1000 mL REG.No :
PRODUCED BY :
PT. Satoria Aneka Industri, Pasuruan – Jawa Timur Each of 500 mL soluition contains:
Calcium Chloride ( CaCl .2H O ) 2 2 0.10 g Ion Equivalent : +
Potassium Chloride ( KCl ) 0.15 g Na 130 mEq/L +
Sodium Chloride ( NaCl ) 3.00 g K 4 mEq/L Sodium Lactate ( C H NaO ) 3 5 3 1.60 g Lactate ( HCO ) 27.5 mEq/L3
-Water for Injection ad 500 mL Cl 109.5 mEq/L ++
Osmolarity 274 mOsm/L Ca 2.7 mEq/L DRUG MECHANISM :
- Sodium Chloride is a salt which is essential to maintain osmotic blood pressure and body tissues.
- Potassium Chloride is a salt to treat hypokalemia and/or hypochloremia condition. - Sodium Lactate is a salt needed for urgent treatment of metabolic acidosis condition. - Calcium Chloride is a salt which is important to maintain normal muscular and nerve
functions. INDICATION :
- To replace lost body fluids in acid-base or minor acidosis condition. - As a first hand solution to replace lost body fluids in an emergency situation. - A therapy to maintain the balance of body fluid in pre-during-post operation situations. - To solve dehydration of irterstitial liquid which is administered after colloid liquid has
been delivered.
DOSAGE AND ADMINISTRATION :
The flow rate recommended for IV injection is 2.5 mL/kg bodyweight/ hour ; this is about 60 drops/70 kg bodyweight/minute or 180 mL/70 kg bodyweight/hour.
CONTRAINDICATION :
- Patient with hyperhydration, hypernatremia, hyperkalemia conditions. - Patient with renal failure, severe hepatic insufficiency and lactic acidosis.
CAUTION :
- This solution should be used with care in patients with congestive heart failure, renal failure, hypoproteinemia, peripheral edema, or pulmonari.
- This solution should be used with caution in children and elderly, due to hypertension or pregnancy toxemia.
- In case of long treatment, periodical laboratories test is required to monitor ionogramme serum, acid-base and fluid balance.
-Overdose treatment has to be avoided to prevent hypokalemia condition. ATTENTION :
Don’t be used if the bottle is damaged, has cloudy solution, or contains particles. STORAGE CONDITION :
The product has to be stored below 30 C.
PRESCRIPTION ONLY PACKAGING : Plastic Bottle 250 mL
Plastic Bottle 500 mL Plastic Bottle 1000 mL REG. No :
PRODUCED BY :
PT. Satoria Aneka Industri, Pasuruan – Jawa Timur Each of 500 mL solution contains :
Sodium Chloride 4.5 g Water for Injection ad 500 mL Osmolarity 308 mOsm/L
Na 154 mEq/L
Cl 154 mEq/L
DRUG MECHANISM :
- Sodium Chloride is a salt which is essential to maintain osmotic blood pressure and body’s tissues.
INDICATION :
- To replace lost body fluids.
- To replace fluids in alkalosis hypochloremia condition. DOSAGE AND ADMINISTRATION :
- The flow rate recommended for IV injections 7.7 mL/kg bodyweight/hour ; this is about 180 drops/70 kg bodyweight/minute.
- Average dose for patient is 1000 mL / 70 kg bodyweight/day.
- Always use according to physician’s instructions. Dosage or injection should be used in accordance with the condition of each patient.
CONTRAINDICATION :
Patients with hypernatremia, acidosis, hypokalemia. SIDE EFFECTS :
- Reactions that may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, thrombosis or vein phlebitis extending from the site of injection and extravasation.
INTRAVENOUS SOLUTION
INO NS 0.9% - SODIUM CHLORIDE 0.9%
CAUTION :
- This solution should be used with care in patients with congestive heart failure, renal failure, hypoproteinemia, peripheral edema, or pulmonari.
- This solution should be used with caution in children and elderly, due to hypertension or pregnancy toxemia.
- In case of long treatment, periodical laboratories test is required to monitor ionogramme serum, acid-base and fluid balance.
-Overdose treatment has to be avoided to prevent hypokalemia condition. ATTENTION :
Don’t be used if the bottle is damaged, has cloudy solution, or contains particles. STORAGE CONDITION :
The product has to be stored below 30 C.
PRESCRIPTION ONLY PACKAGING : Plastic Bottle 250 mL
Plastic Bottle 500 mL Plastic Bottle 1000 mL REG. No :
PRODUCED BY :
PT. Satoria Aneka Industri, Pasuruan – Jawa Timur +
-Each of 500 mL solution contains : Sodium Chloride 4.5 g Water for Injection ad 500 mL Osmolarity 308 mOsm/L
Na 154 mEq/L
Cl 154 mEq/L
DRUG MECHANISM :
- Sodium Chloride is a salt which is essential to maintain osmotic blood pressure and body’s tissues.
INDICATION :
- To replace lost body fluids.
- To replace fluids in alkalosis hypochloremia condition. DOSAGE AND ADMINISTRATION :
- The flow rate recommended for IV injections 7.7 mL/kg bodyweight/hour ; this is about 180 drops/70 kg bodyweight/minute.
- Average dose for patient is 1000 mL / 70 kg bodyweight/day.
- Always use according to physician’s instructions. Dosage or injection should be used in accordance with the condition of each patient.
CONTRAINDICATION :
Patients with hypernatremia, acidosis, hypokalemia. SIDE EFFECTS :
- Reactions that may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, thrombosis or vein phlebitis extending from the site of injection and extravasation.
INOCHI - INFUSION ADMINISTRATION SET
SYRINGE WITH NEEDLE
INSTRUCTION FOR USE
1. Use immediately after opening unit package.
2. Use once, dispose of properly and safely to avoid nosokomial infection. 3. Affix needle firmly before use.
4. Do not use if the unit package or product has been opened or damaged,
STERILE–NON TOXIC-LATEX FREE-NON PYROGENIC
STERILE–NON TOXIC-NON PYROGENIC
SYRINGE - INOCHI-INO 1 ml - INOCHI-INO 3ml - INOCHI-INO 5 ml - INOCHI-INO 10ml - INOCHI-INO 20 ml INFUSION SET INOCHI-INO 20 drops/mL :
- Infusion Set with Y-Port Injector - Infusion Set with Air-Inlet Neddle - Infusion Set with Flashball Injector INSTRUCTION FOR USE
1. Close control clamp.
2. Remove protector from plastic spike and insert into outlet of solution container.
3. Suspend container. Half fill drip chamber by squeezing and releasing. Do not fill completely. 4. Remove protector from luer end and firmly attach needle.
5. Holding needle upright, open clamp and allow solution to displace air entirely in tubing and needle. Close clamp.
6. Perform venipuncture and regulate flow by opening clamp. Designed to deliver approximately 15 drops/mL.
7. Discard after single use.
8. Do not use if the package has been opened or damaged.
DISTRIBUTED BY : PT. SATORIA ANEKA INDUSTRI Kemenkes RI No :
MANUFACTURED BY : JIANGXI HONGDA MEDICAL EQUIPMENT DISTRIBUTED BY : PT. SATORIA ANEKA INDUSTRI
Kemenkes RI No :